Technical Analysis for RNAZ - TransCode Therapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Support | Bullish | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
Stochastic Reached Oversold | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Crossed Above 20 DMA | Bullish | 10.48% | |
Crossed Above 50 DMA | Bullish | 10.48% | |
Volume Surge | Other | 10.48% | |
Wide Bands | Range Expansion | 10.48% | |
Gapped Down | Weakness | 10.48% |
Alert | Time |
---|---|
20 DMA Support | about 21 hours ago |
Rose Above Previous Day's High | about 21 hours ago |
2x Volume Pace | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
3x Volume Pace | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/30/2023
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs for the treatment of metastatic diseases. The company's lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. Its products in discovery and preclinical stage include MicroRNA-10b, TTX-siPDL1, TTX-siLIN28b, and TTX-RIGA, which focuses on treating various cancers. The company was incorporated in 2016 and is based in Boston, Massachusetts
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Preclinical Stage Product Metastatic Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Preclinical Stage Product Metastatic Cancer
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 309.6 |
52 Week Low | 0.42 |
Average Volume | 1,228,815 |
200-Day Moving Average | 16.06 |
50-Day Moving Average | 0.69 |
20-Day Moving Average | 0.73 |
10-Day Moving Average | 0.94 |
Average True Range | 0.24 |
RSI (14) | 50.98 |
ADX | 45.18 |
+DI | 38.83 |
-DI | 26.80 |
Chandelier Exit (Long, 3 ATRs) | 1.29 |
Chandelier Exit (Short, 3 ATRs) | 1.14 |
Upper Bollinger Bands | 1.30 |
Lower Bollinger Band | 0.17 |
Percent B (%b) | 0.57 |
BandWidth | 153.78 |
MACD Line | 0.08 |
MACD Signal Line | 0.07 |
MACD Histogram | 0.0097 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.15 | ||||
Resistance 3 (R3) | 1.15 | 1.04 | 1.09 | ||
Resistance 2 (R2) | 1.04 | 0.95 | 1.04 | 1.07 | |
Resistance 1 (R1) | 0.92 | 0.90 | 0.98 | 0.92 | 1.05 |
Pivot Point | 0.81 | 0.81 | 0.84 | 0.81 | 0.81 |
Support 1 (S1) | 0.70 | 0.72 | 0.75 | 0.69 | 0.56 |
Support 2 (S2) | 0.58 | 0.67 | 0.58 | 0.54 | |
Support 3 (S3) | 0.47 | 0.58 | 0.52 | ||
Support 4 (S4) | 0.47 |